Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
High dose chemotherapy (HDT) followed by autologous peripheral blood stem cell transplantation (ASCT) is standard of care including a curative treatment option for several cancers. While much is known about the management of patients with allogenic SCT at the intensive care unit (ICU), data regardin...
Main Authors: | Panagiotis Karagiannis, Lena Sänger, Winfried Alsdorf, Katja Weisel, Walter Fiedler, Stefan Kluge, Dominic Wichmann, Carsten Bokemeyer, Valentin Fuhrmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1678 |
Similar Items
-
The effectiveness of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment
by: T. V. Yukhta, et al.
Published: (2019-12-01) -
Successful Treatment with High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in a Patient with Metastatic Germ Cell Tumor
by: Jung Min Lee, et al.
Published: (2021-06-01) -
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma
by: Popp, Henning, et al.
Published: (2007-06-01) -
High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
by: Nikita E. Mochkin, et al.
Published: (2020-07-01) -
Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
by: Ji Won Lee, et al.
Published: (2017-05-01)